|
|
|
Vol. 13, No. 18, pp. 2425-2438, September 15, 1999
1 European Molecular Biology Laboratory, D-69117 Heidelberg, Germany; 2 Department of Biology, Williams College, Williamstown, Massachusetts 01267 USA
| |
Abstract |
|---|
|
|
|---|
The characterization of a novel yeast-splicing factor, Luc7p, is presented. The LUC7 gene was identified by a mutation that causes lethality in a yeast strain lacking the nuclear cap-binding complex (CBC). Luc7p is similar in sequence to metazoan proteins that have arginine-serine and arginine-glutamic acid repeat sequences characteristic of a family of splicing factors. We show that Luc7p is a component of yeast U1 snRNP and is essential for vegetative growth. The composition of yeast U1 snRNP is altered in luc7 mutant strains. Extracts of these strains are unable to support any of the defined steps of splicing unless recombinant Luc7p is added. Although the in vivo defect in splicing wild-type reporter introns in a luc7 mutant strain is comparatively mild, splicing of introns with nonconsensus 5' splice site or branchpoint sequences is more defective in the mutant strain than in wild-type strains. By use of reporters that have two competing 5' splice sites, a loss of efficient splicing to the cap proximal splice site is observed in luc7 cells, analogous to the defect seen in strains lacking CBC. CBC can be coprecipitated with U1 snRNP from wild-type, but not from luc7, yeast strains. These data suggest that the loss of Luc7p disrupts U1 snRNP-CBC interaction, and that this interaction contributes to normal 5' splice site recognition.
[Key Words: Pre-mRNA processing; U1 snRNP; 5' splice site recognition; cap-binding complex; alternative splicing]
| |
Introduction |
|---|
|
|
|---|
The formation of mRNAs in the nuclei of eukaryotic cells involves
several co- and post-transcriptional processing
events. These include 5' end capping, 3' end
formation, usually by cleavage and polyadenylation, and frequently the
removal of intervening sequences by splicing. Pre-mRNA splicing can be
conceptually divided into distinct stages. The initial step is
recognition of conserved intronic sequences near the 5' splice site
and branchpoint region by a subset of splicing factors. This is
followed by assembly of multiple additional splicing factors to form
the spliceosome. Rearrangements within the spliceosome then occur,
accompanying the two chemical steps of intron removal. Spliced mRNA is
released for export to the cytoplasm while intronic RNA is degraded and splicing factors are recycled (Moore et al. 1993
).
The first defined step of splicing consists of the formation of
commitment complexes in yeast (Séraphin and Rosbash 1989a
) and E
complex in mammals (Michaud and Reed 1991
). In yeast, two forms of
commitment complex are experimentally separable, CC1 and CC2
(Séraphin and Rosbash 1989a
). It is likely, though not definitively proven, that CC1 is a precursor of CC2. Both contain U1
snRNP, which interacts with the 5' splice site. CC2 additionally contains at least two proteins, BBP and Mud2p, that bind to the branchpoint sequence and an adjacent pyrimidine-rich tract,
respectively (Séraphin and Rosbash 1991
; Abovich et al. 1994
;
Abovich and Rosbash 1997
; Berglund et al. 1998
). mBBP/SF1
and U2AF65, the mammalian homologs of these proteins, are present in E
complex (Ruskin et al. 1988
; Michaud and Reed 1991
, 1993
; Krämer
1992
; Rain et al. 1998
).
These facts about early steps in spliceosome formation point to a
critical role for U1 snRNP in 5' splice site definition and choice,
and lead to the question of how the choice between two alternative
5' splice sites that can both be spliced to a common 3' splice
site is made. Examination of alternative splicing in vertebrates
suggests that factors that are not components of U1 snRNP can influence
the selection of splice sites (for examples, see Chabot and Steitz
1987
; Eperon et al. 1993
; Kohtz et al. 1994
). Recent work in yeast has
shown, however, that at least one U1 snRNP protein can also influence
5' splice site choice (Puig et al. 1999
).
Yeast U1 snRNA is significantly larger than vertebrate U1 snRNA
(Kretzner et al. 1987
; Siliciano et al. 1987
). The yeast-specific regions of the RNA are not absolutely essential for survival, but
nevertheless they play a role in splicing (Liao et al. 1990
; Siliciano
et al. 1991
). Yeast U1 snRNP, as biochemically purified, is
considerably more complex than vertebrate U1 snRNP. Both contain the Sm
core proteins and three U1-specific proteins, U1
70K/Snp1p, U1A/Mud1p, and
U1C/yU1-C. In addition, the yeast U1 snRNP contains at
least six specific proteins (Snu71p, Snu65p, Snu56p, Prp39p, Prp40p,
and Nam8p) that have no currently characterized vertebrate homologs
(Neubauer et al. 1997
; Gottschalk et al. 1998
). U1 snRNP interacts with
the 5' splice site via base-pairing through U1 snRNA (Zhuang and
Weiner 1986
; Séraphin et al. 1988
; Siliciano and Guthrie 1988
;
Séraphin and Rosbash 1989b
). Recent data indicate that the yeast
U1 snRNP proteins also make extensive contact with the pre-mRNA both
upstream and downstream of the 5' splice site (Puig et al. 1999
;
Zhang and Rosbash 1999
). These interactions are likely to increase the
stability of U1 snRNP-5' splice site binding. In addition, at least
one U1 snRNP protein-pre-mRNA interaction, involving Nam8p, is
affected by the sequence of the pre-mRNA to which the protein binds.
The sequence specificity of this interaction can affect 5' splice
site choice (Puig et al. 1999
).
Other signals on a pre-mRNA can also influence binding of U1 snRNP to a
5' splice site or other steps that affect the efficiency of intron
recognition and removal. Examples include the effects of adjacent
introns or 3' end formation signals (for review, see Berget 1995
),
exon enhancer sequences (for review, see Hertel et al. 1997
), and, in
the case of the cap-proximal intron, the cap structure (Konarska et al.
1984
; Krainer et al. 1984
; Ohno et al. 1987
).
The effect of the cap structure is mediated by the nuclear cap-binding
complex (CBC), a conserved heterodimeric complex composed of CBP80 and
CBP20 (Izaurralde et al. 1994
, 1995
; Colot et al. 1996
; Görlich
et al. 1996
; Lewis et al. 1996a
,b
). In both yeast and mammals, CBC
appears to act by increasing the efficiency of recognition of the
cap-proximal 5' splice site by U1 snRNP during commitment
complex/E complex assembly (Colot et al. 1996
; Lewis et
al. 1996a
,b
). Much of the initial evidence for this mechanism came from
biochemical experiments (Izaurralde et al. 1994
; Lewis et al. 1996b
)
but in yeast a considerable body of genetic data indicates that CBC
plays an important role in commitment complex assembly. The gene
encoding yCBP20, MUD13, was identified by a mutation that
caused synthetic lethality in combination with a nonlethal deletion of
part of U1 snRNA (Colot et al. 1996
). A more extensive search for genes
whose mutation led to synthetic lethality in the absence of CBC (Fortes
et al. 1999
) led to the identification of LUC genes
(lethal unless CBC is produced).
The LUC collection includes genes that encode several
components of the commitment complex, including both
Mud2p/Luc2p and several protein components of yeast U1
snRNP. Some of these genes encode proteins conserved between yeast and
vertebrates, like SmD3/Luc6p or
Mud1p/Luc1p, the yeast homolog of the human U1A protein,
and others encode several of the recently identified yeast-specific U1
snRNP proteins, Nam8p/Luc3p, Snu56p/Luc4p, and Snu71p/Luc5p (Neubauer et al.
1997
; Gottschalk et al. 1998
; Fortes et al. 1999
).
One functionally uncharacterized gene identified in the screen was named LUC7. Here we demonstrate that Luc7p is an additional component of the yeast U1 snRNP. LUC7 is an essential gene, and Luc7p is required for commitment complex formation in vitro. In the presence of a temperature-sensitive form of Luc7p, the protein composition of U1 snRNP is altered. Although the defective U1 snRNP still appears to be partially active in vivo, splicing efficiency is reduced and 5' splice site selection is altered. The change in 5' splice site recognition is similar to that seen in the absence of CBC, suggesting that CBC-U1 snRNP interaction is affected by the absence of Luc7p. Biochemical data that support this hypothesis are presented.
| |
Results |
|---|
|
|
|---|
LUC7 was originally identified by complementation of a
mutation that caused lethality in yeast strains that did not produce CBC, but was not further characterized (Fortes et al. 1999
; see also
below). As a first step in the analysis of LUC7, the phenotype caused by deletion of the gene was determined. One allele of
LUC7 was disrupted in a diploid yeast strain by replacement of
the entire ORF with sequences encoding the wild-type URA3
gene. After sporulation and dissection, maximally two spores from each
tetrad gave rise to a growing colony (Fig. 1A). The
growing cells contained the nondisrupted LUC7 allele,
indicating that LUC7 is an essential gene. While this work was
in progress, LUC7 was disrupted as part of a systematic
analysis of Saccharomyces cerevisiae chromosome IV, and
reported to be essential for growth (Lopez et al. 1998
). Separately, in
a screen for temperature-sensitive mutants blocked in the cell cycle, a
further allele of LUC7 was identified, luc7-1 (see
Materials and Methods). On shift to 37°C, haploid strains carrying
luc7-1 exhibited a growth defect after ~2 hr, and they stopped growing altogether after ~5 hr (Fig. 1B).
|
The PF433 strain was isolated in a synthetic lethal screen with yCBC.
This strain carries the luc7-2 allele and, in addition, lacks
chromosomal copies of both GCR3 and MUD13, the genes
encoding the two subunits of yeast CBC. This genetic combination causes synthetic lethality (Fortes et al. 1999
). PF433 can grow when carrying
a plasmid expressing GCR3 and MUD13, as well as the
URA3 marker. When transferred to FOA-containing plates to
select for loss of this plasmid, luc7-2 cells could not grow
(Fig. 1C, left). To analyze the ability of the two mutant forms of
LUC7 to complement the synthetic lethal phenotype,
complementation tests were carried out. The growth defect on FOA was
complemented by an expression plasmid carrying wild-type LUC7
but not by plasmids from which either the luc7-1 or
luc7-2 alleles were expressed (Fig. 1C). Similarly, the
temperature-sensitive defect of a strain carrying luc7-1 was
complemented by a plasmid expressing LUC7, but not by plasmids
expressing either luc7-1 or luc7-2 (Fig. 1D).
Luc7p, the conceptual protein product of LUC7 (Fig.
2), includes sequences that encode two putative zinc
finger motifs, structures known to bind either nucleic acids or
proteins. The first zinc finger is of the C3H (cysteine 3, histidine)
type, whereas the second is a typical C2H2 zinc finger of the class
often found in RNA-binding proteins (Matsushima et al. 1997
).
Sequencing and further analysis of the mutant alleles revealed that the
luc7-1 phenotype was due to a point mutation that lies between
the two zinc fingers (glutamate to lysine at amino acid position 149), whereas the luc7-2 phenotype was due to a frameshift at
position 195 (Fig. 2B), just upstream of the second zinc finger.
|
Examination of protein sequence databases revealed the existence of
metazoan relatives of Luc7p, including three in human and
Caenorhabditis elegans (Fig. 2A) and others in
Arabidopsis thaliana, Drosophila melanogaster, and
other eukaryotes. The regions encoding the zinc finger motifs are
particularly highly conserved (57% similarity conserved across the
whole family) (Fig. 2). A phylogenetic tree was constructed with the
sequence information. LUC7 appears to have been duplicated
early in evolution, leading to the Luc7A and Luc7B subfamilies in
higher eukaryotes (Fig. 2A). Interestingly, all metazoan LUC7
family members contain carboxy-terminal extensions with multiple
arginine-serine (RS) or arginine-glutamate (RE) repeats,
characteristic of a large number of metazoan splicing factors
(Neugebauer et al. 1995
; Staknis and Reed 1995
) (Fig. 2A). This,
together with the synthetic lethality data, suggested that Luc7p might
be involved in pre-mRNA splicing.
Luc7p mutation affects splicing
The effect of mutation of LUC7 on pre-mRNA splicing was
tested in vivo. Initially, a series of reporter constructs derived from
the ribosomal protein 51A (RP51A) gene were utilized. They contained
either the wild-type RP51A intron or derivatives whose splicing
efficiency was reduced by mutation at the 5' splice site or
branchpoint (Teem and Rosbash 1983
; Jacquier et al. 1985
; Pascolo and
Séraphin 1997
). Splicing of these three pre-mRNAs was tested with RNA extracted from luc7-1 cells grown at either
permissive (30°C) or nonpermissive (37°C) temperature either in
the presence (+) or absence (
) of a plasmid from which wild-type
Luc7p was expressed (Fig. 3). As demonstrated
previously, expression of Luc7p complements the luc7-1
phenotype (Fig. 1).
|
Splicing of the wild-type RP51A intron was affected to only a minor
extent by the luc7-1 mutation, as seen by the small increase in pre-mRNA relative to mRNA in the strain at 37°C (Fig. 3, lanes 1-6, cf. + and
lanes). Splicing of the chromosomally encoded RP51A and actin pre-mRNAs was also not detectably reduced (data not
shown). However, pre-mRNA accumulation was readily visible in cells
carrying luc7-1 when the splicing efficiency of the reporter was compromised by mutation of either the 5' splice site from GUAUGU to GUAUaU or the branchpoint from UACUAAC to UAuUAAC (Fig. 3,
lanes 7-18). The defect in splicing was already detected at permissive
temperature by the reporter with the mutant 5' splice site (lanes
7,8), although it was exacerbated further by raising the temperature to
37°C (lanes 9-12).
Luc7p is a component of U1 snRNP
As a first step to examining the role of Luc7p in splicing in more
detail, its association with U snRNAs was examined. To this end, a
yeast strain carrying a protein A-tagged version of Luc7p was
constructed. Extracts were made from this strain, a control strain
lacking a protein A tag, and, as a positive control, a strain carrying
a protein A-tagged version of the U1 snRNP component Nam8p (Gottschalk
et al. 1998
; Puig et al. 1999
). The extracts were fractionated on
IgG-agarose and RNA extracted from input, supernatant, and pellet
fractions was analyzed by primer extension. U snRNAs immunoprecipitated
with anti-trimethyl guanosine cap antibodies were used as size markers
(Fig. 4A, lane 11). Only minor background quantities
of U snRNAs were found in the control pellet fraction (Fig. 4A, lanes
1-3). However, U1 snRNA was specifically and efficiently precipitated
from protein A-tagged Nam8p (Nam8p-ProtA) and Luc7p-ProtA strains
(lanes 4-9), suggesting that Luc7p, like Nam8p, is a U1 snRNP component.
|
To confirm this conclusion, similar experiments were carried out, but
instead of analyzing U snRNAs, proteins that coprecipitated with
Luc7p-ProtA were examined. In this case, proteins precipitated via
association with Nam8p-ProtA and with a protein A-tagged version of
Mud10p/Snu56p were also examined.
Mud10p/Snu56p is a U1 snRNP protein (Gottschalk et al.
1998
) that, like Nam8p and Luc7p, can be mutated to a form that causes
synthetic lethality in the absence of CBC (Fortes et al. 1999
).
Two U1 snRNP proteins, Snu71p and Nam8p (Gottschalk et al. 1998
),
coprecipitated with Luc7p-ProtA even after washing in buffer containing up to two molar NaCl, indicating that Luc7p is, like these
two proteins, a stable U1 snRNP component (Fig. 4B,C). This was
confirmed in an independent biochemical study of U1 snRNP composition
(Rigaut et al. 1999
). Proteins that exhibit a weaker association with
U1 snRNP were examined next. A minor amount of yCBP80 and Npl3p (see
Gottschalk et al. 1998
) also specifically coprecipitated with all three
protein A-tagged U1 snRNP proteins (Fig. 4B,C). However, these latter
associations were disrupted by moderate and low salt washes,
respectively (Fig. 4B,C). There seemed to be no preferential
association between any of the U1 snRNP proteins tested and yCBP80
under these conditions, suggesting that the precipitation seen reflects
association of a fraction of CBC with the U1 snRNP.
Mutation of Luc7p destabilizes U1 snRNP
To further examine the basis for the splicing defect, U1 snRNP was
examined in luc7-1 cells grown at 30°C or 37°C . Cells containing either only the luc7-1 allele (
) or also
carrying LUC7 on a plasmid (+) were compared. No difference in
the accumulation of U1 snRNA was seen in noncomplemented
luc7-1 cells, even 5 hr after transfer to 37°C (Fig.
5A). The luc7-1 mutation did, however, affect the association of Luc7p with U1 snRNA. When U1 snRNA
association to protein A-tagged wild-type Luc7p (Luc7p-ProtA) and
Luc7-1p-ProtA was compared, U1 could only be coprecipitated with the
wild-type protein. Luc7-1p association with U1 snRNA was not detectable above background even when U1 snRNP was prepared under mild conditions (0.15 M NaCl) from cells grown at permissive temperature
(Fig. 5B, cf. lanes 1-6 with 7-10). By Western blotting, no change in the amount of Luc7-1p-ProtA was seen after temperature shift (data not
shown), demonstrating that the loss of U1 snRNP association was not due
to degradation of the protein.
|
To examine U1 snRNP composition in the mutant strain extracts prepared
from either luc7-1 cells or luc7-1 cells complemented with LUC7 were immunoprecipitated with three different
antibodies. The first was directed against the trimethyl cap structure
and the other two against the U1 snRNP proteins Snu71p and Nam8p
(Gottschalk et al. 1998
). U1 snRNA was efficiently precipitated with
anti-trimethyl guanosine cap antibodies (Fig. 5C, cf. lanes 1-2 with
15-20). Because, at least in vertebrates, trimethyl capping requires
assembly of U snRNAs with the U snRNP core proteins (Mattaj 1986
), this suggested that U1 snRNP assembly had occurred to some extent in luc7-1 cells. U1 snRNA immunoprecipitation by anti-Nam8p
antibodies was also efficient (lanes 9-14). In contrast, only
background levels of U1 snRNA were precipitated with anti-Snu71p
antibodies in the absence of LUC7, even when
immunoprecipitation was carried out in 0.15 M NaCl on
extracts of cells grown at permissive temperature (lanes 3-8).
Anti-Snu71p antibodies immunoprecipitated Snu71p, but not Nam8p, from
luc7-1 cells (lanes 3-8, bottom). Conversely, anti-Nam8p
antibodies precipitated Nam8p but not Snu71p from the mutant cells
(lanes 9-14, middle). Similarly, anti-trimethyl cap antibodies only
precipitated Snu71p in the presence of wild-type Luc7p (lanes 15-20).
These results demonstrate the lack of association of Snu71p with Nam8p
or with U1 snRNA in extracts of the luc7-1 strain. This defect
in association is not due to a decrease in the amount of either Snu71p
or U1 snRNA present in the mutant cells (Fig. 5C).
A more complete analysis of U1 snRNP composition in luc7-1
cells was undertaken, with the recently developed TAP
(tandem affinity purification)
method (Rigaut et al. 1999
). Because the results in Figure 5C indicated
that Nam8p remained in the U1 snRNP in the mutant cells, tagged Nam8p
was chosen for the analysis. Because of problems in extract preparation
from luc7-1 cells at nonpermissive temperature, U1 snRNP from
wild-type cells was compared with U1 snRNP from luc7-1 cells
grown at 30°C, in which Luc7p-U1 snRNA interaction is already
defective (Fig. 5B).
The protein profile of purified U1 snRNP (Fig. 5D, left) was compared
with previous purifications (Neubauer et al. 1997
; Gottschalk et al.
1998
; Rigaut et al. 1999
). Many U1 snRNP proteins were detected in U1
snRNP purified from luc7-1 cells (Fig. 5D, right). The SmD
proteins and several yeast U1-specific proteins were present in both
cases. As expected from the results in Figure 5, B and C, both Luc7p
and Snu71p were absent from the U1 snRNP extracted from mutant cells
(Fig. 5D), although both proteins were present at normal levels in the
extracts as determined by Western blotting (Fig. 5C; data not shown).
This indicates that the stable association of these proteins with the
snRNP depends on the integrity of Luc7p. Other changes in U1 snRNP
composition in luc7 cells are possible. The relative amount of
protein in the Prp39p/Prp40p doublet was reduced in
luc7-1 extract (Fig. 5D). Only peptides from Prp39p were
detected when this band was subjected to mass spectrometric analysis
(data not shown). Similarly, no peptides corresponding to Prp42p were
detected in the samples prepared from luc7-1 cells. Mud10p/Snu56p was, however, found to be present in U1
snRNP in the luc7-1 extract (data not shown). The negative
results with Prp40p and Prp42p suggest that these proteins, like
Snu71p, may be less stably associated with U1 snRNP in luc7-1
cells, but this possibility needs to be tested more definitively. The
apparent increase in recovery of a protein that migrated just below
U1Cp was not reproduced in other experiments, whereas all the other changes were reproducibly seen (data not shown).
Luc7p is required for commitment complex assembly
U1 snRNP is a component of both yeast commitment complexes, CC1 and
CC2 (Séraphin and Rosbash 1989a
, 1991
). Commitment complexes formed using extracts of a protein A-tagged Luc7p strain could be
supershifted with IgG (data not shown). Thus, Luc7p is found in both
commitment complexes. To determine whether luc7-1 extracts could form commitment complexes, native gel electrophoresis was carried
out under conditions in which commitment complex formation is favored
with either a wild-type pre-mRNA, able to form CC2, or a mutant
pre-mRNA in which the branchpoint sequence has been deleted and that is
therefore only able to form CC1 (Séraphin and Rosbash 1989a
).
Extracts of luc7-1 cells, whether grown at 30°C or 37°C,
exhibited strong defects in CC1 and CC2 formation (Fig. 6, lanes
3,9,17,22,29,37). As expected, these defects were reversed when luc7-1 cells were complemented with a
LUC7-expressing plasmid (Fig. 6, lanes 5-8, 13-16, 25-28,
33-36). Commitment complex assembly could also be partly restored to
luc7-1 extracts by the addition of recombinant Luc7p produced
in Escherichia coli (lanes 9-12, 17-20, 29-32, 37-40).
Thus, the biochemical defect in luc7-1 extracts, a failure to
assemble stable commitment complexes, could be rescued by provision of
Luc7p alone. Note that the extracts were prepared in such a way that
some prespliceosomes or spliceosomes were formed on the wild-type
pre-mRNA substrate (Fig. 6, lanes 25-40). Complementation with Luc7p
rescued the defect in both spliceosome assembly (lanes 25-40) and in
pre-mRNA splicing (data not shown) of the luc7-1 extracts.
|
Mutation of LUC7 affects 5' splice site choice
The results presented in Figure 5 suggest that U1 snRNP composition
may be altered in luc7 mutant cells even if splicing of at
least the RP51A reporter was still reasonably efficient (Fig. 3).
Therefore, we assayed more stringently for a functional defect in the
mutant U1 snRNP. Because LUC7 interacts genetically with CBC,
it was reasoned that mutation of Luc7p might affect the choice of a
5' splice site in relation to its proximity to the 5' cap. Pre-mRNAs based on the RP51A pre-mRNA, but containing duplicated 5'
splice sites and flanking sequences (Séraphin and Kandels-Lewis 1993
), were used as reporters in these experiments to examine whether
mutation of LUC7 would affect the two competing 5' splice sites differentially. We assayed constructs in which both 5' splice sites were wild type, or where either the cap distal, the cap proximal,
or both 5' splice sites were mutant. In all cases, the mutated
5' splice sites carried UC instead of AG at the last two positions
of the 5' exon (Séraphin and Kandels-Lewis 1993
).
Splicing of these constructs was examined by primer extension, and the
products of splicing from the cap-distal and cap-proximal 5' splice
sites were detected (Fig. 7A, the top and bottom groups of products,
respectively). With three of the reporters, a clear reduction in the usage of the cap-proximal 5' splice site was seen
in luc7-1 cells grown at 37°C (Fig. 7A,
lanes
1,3,9,11,13,15). These effects were reversed when the luc7-1
cells were complemented with plasmid-borne LUC7 (Fig. 7A, + lanes 2,4,10,12,14,16). Only when the cap-distal 5' splice site was
mutant and the cap-proximal wild type (lanes 5-8) was the change in
relative usage of the two splice sites in the absence of Luc7p not
observed. Thus, where two identical 5' splice sites are in
competition, the presence of Luc7p favors splicing to the cap-proximal
of the two. These results are summarized in Figure 7C. Here the ratio
of usage of the proximal and distal splice sites in the mutant strain
are presented with reference to the wild type, whose ratio has been set
to 1. Thus, a value lower than 1 represents a relative preference for
the distal 5' splice site. Similar effects on relative usage of the
two splice sites were obtained when a gcr3 deletion strain, which lacks yCBP80, was compared with a strain producing CBC (Fig. 7B,
lanes 1-8). For reasons that are not understood, the defect in this
case does not appear evenly distributed among the transcripts arising
from different transcription initiaton points. When quantified, however, the overall proximal:distal ratio changes similarly in luc7 and gcr3 cells. Similar results were observed in
strains lacking yCBP20 (data not shown) or lacking both components of CBC (Fig. 7C).
|
To test whether this phenotype was unique for luc7 and
cbc mutants, yeast strains mutant in two other commitment
complex proteins were analyzed. Mud1p and Mud2p were chosen as, like
Luc7p, they can both cause synthetic lethality in the absence of CBC
(Fortes et al. 1999
). Mud1p is a U1 snRNP protein, whereas Mud2p binds to the branchpoint and has been shown to physically interact with CBC
(Fortes et al. 1999
). In vivo splicing of reporters containing duplicated 5' splice site regions was assayed in mud1 or
mud2 deletion strains. The effect of the lack of these
proteins on splice site choice was less pronounced than the lack of
Luc7p or CBC (Fig. 7C). Lack of Mud1p caused a preference for the cap proximal site, whereas lack of Mud2p caused the cap distal site to be
slightly favored (Fig. 7C). We also tested the effect of NAM8
deletion on splice site choice using these reporter constructs. As
predicted by a previous study (Puig et al. 1999
; O. Puig and B. Séraphin, pers. comm.) the absence of Nam8p favored use of the
cap proximal 5' splice site, although this effect was minor with
the reporter used here (data not shown).
The concordance of the results in the luc7 and cbc strains suggested that the defective U1 snRNP present in luc7 mutant cells might have a reduced ability to interact with CBC. To test this directly, we used the assay introduced in Figure 4. A luc7-1 strain containing a protein A-tagged version of Nam8p was constructed. The Nam8p-ProtA fusion was used as it allows quantitative precipitation of U1 snRNPs from both wild-type and luc7-1 strains (Figs. 4 and 5). A fraction of yCBP80 was specifically coprecipitated on IgG beads from extracts of a strain containing Nam8p-ProtA but not wild-type Nam8p (Fig. 4B and Fig. 8, lanes 2,3,5,6). The amount of bound yCBP80 was drastically reduced in extracts of luc7-1 cells containing Nam8p-ProtA and grown at permissive temperature (Fig. 8, lanes 4,7), in which U1 snRNP composition is already altered. The amount of bound yCBC was more drastically affected when extracts were made from luc7-1 cells grown at the nonpermissive temperature (data not shown). This reduction in coprecipitation was not due to instability of yCBP80, because similar amounts of the protein were present in the flowthrough from the column (Fig. 8, lanes 2-4). Thus, interaction between U1 snRNP and yCBC is disrupted in luc7-1 cell extracts.
|
| |
Discussion |
|---|
|
|
|---|
Luc7p, a newly identified component of U1 snRNP, is described.
Whereas mammalian U1 snRNP has a relatively small number of associated
components, the Sm core proteins, U1 snRNA, and three U1-specific
proteins, U1-70K, U1A, and U1C (Lührmann et al. 1990
), yeast U1
snRNP is more complex. U1 snRNA in yeast is considerably larger than in
mammals (Kretzner et al. 1987
; Siliciano et al. 1987
). In addition to
homologs of the mammalian core and U1-specific proteins, yeast U1 snRNP
was shown recently to contain six additional proteins, several encoded
by essential genes (Neubauer et al. 1997
; Gottschalk et al. 1998
). The
identification of Luc7p as an additional U1 snRNP-specific protein
(Rigaut et al. 1999
; this work) brings the total number of protein
components in the yeast snRNP to 17. Given the extensive genetic and
biochemical analysis applied to yeast U1 snRNP, it is probable that
all stably associated proteins have now been described.
Luc7p affects U1 snRNP composition and 5' splice site recognition
Luc7p is encoded by an essential gene, and both in vivo and in vitro
data show that mutation of LUC7 causes a defect in pre-mRNA splicing. The complete defect in all steps of splicing in extracts from
luc7-1 cells (Fig. 6; data not shown) strongly suggests that the reason why Luc7p is essential is because of its participation in
splicing. The lack of a major effect of mutation of Luc7p on efficiently spliced reporter genes in vivo is similar to previous observations with other commitment complex components (Liao et al.
1993
; Abovich et al. 1994
; Colot et al. 1996
; Puig et al. 1999
).
However, it is possible that Luc7p has an additional function that is
not related to pre-mRNA splicing and is essential for yeast growth.
When extracts were prepared from a temperature-sensitive luc7 strain grown at either permissive or nonpermissive temperature, the mutant Luc7p was not detectably associated with either U1 snRNA or other U1 snRNP proteins. In addition, another U1 snRNP component, Snu71p, was also no longer stably bound to the snRNP. Other changes in U1 snRNP composition were observed. However, the in vitro splicing defect in extracts of these mutant cells could be complemented by the simple addition of recombinant Luc7p, suggesting that U1 snRNP could be reassembled from the disassembled components and Luc7p. Although these data are suggestive of a Luc7p-containing U1 snRNP subcomplex, they do not prove its existence. An alternative explanation for the data would be that Luc7p would bind to the partially assembled U1 snRNP and cause a change in the conformation of either its RNA or protein components that allows the formation of a U1 snRNP to proceed to completion. We note that it is difficult to extrapolate directly from these in vitro experiments to the state of assembly of U1 snRNP in vivo, although the in vivo splicing data do indicate that U1 snRNP activity is affected in luc7-1 cells.
The fact that splicing of at least some reporter introns was affected
to only a very minor extent in the temperature-sensitive luc7
strain grown at nonpermissive temperature raises the possibility that
neither Luc7p nor the other components whose stable association with
U1 snRNA depend on Luc7p, notably the essential Snu71p (Gottschalk et
al. 1998
), are absolutely required for the splicing of every intron.
For example, the mutant U1 snRNP subcomplex was sufficient to allow
efficient splicing of the RP51A pre-mRNA. If the essential function of
LUC7, as argued above, is pre-mRNA splicing, there must be at
least one intron in another essential gene whose splicing is defective
enough in luc7 strains to cause inviability. This in turn
suggests that at least Luc7p and Snu71p, and possibly other U1
snRNP-specific proteins, may only be required for splicing of certain
specific introns.
Evidence for this was obtained by analysis of a reporter construct
containing an intron with a duplicated 5' splice site. In the
absence of Luc7p, splicing to the cap-proximal 5' splice site was
greatly reduced, whereas splicing to the cap-distal site was little
affected. Note that because the reporter in question had a duplication
of 25 nucleotides upstream of the 5' splice site and 48 nucleotides
downstream (Séraphin and Kandels-Lewis 1993
), this was unlikely
to be due to an effect on an intrinsic sequence-specific recognition of
the 5' splice sites by U1 snRNP. These sequences all lie within the
region that can be cross-linked to U1 snRNP proteins (Zhang and Rosbash
1999
; Puig et al. 1999
). Rather, it was suggestive of loss of
interactions with factors that contacted the RNA outside of the
duplicated region, either upstream or downstream of the tandem 5'
splice sites, and affected their recognition by U1 snRNP. Analysis of
strains lacking the commitment complex components Mud1p, Mud2p, or
Nam8p showed that removal of these proteins also affected splice site
choice in the competition assay. The effects of depletion of individual commitment complex components on splice site choice were, however, both
quantitatively and qualitatively diverse.
U1 snRNP-CBC interaction
LUC7 was identified by a mutation that caused lethality in
the absence of CBC, and a defect in recognition of a cap proximal intron, similar to that of luc7-1 cells, was seen in strains
lacking yCBC. Biochemically, this defect was observed as a lack of
coimmunoprecipitation of yCBC with U1 snRNP, supporting previous data
from both yeast and human systems that suggested a direct or indirect
role for CBC in U1 snRNP interaction with cap-proximal 5' splice
sites (Colot et al. 1996
; Lewis et al. 1996a
,b
). We have failed in
attempts to detect a direct physical interaction between Luc7p and yCBC (Fortes et al. 1999
). It is therefore likely that the absence of Luc7p
from the U1 snRNP changes the snRNP conformation such that interaction
between yCBC and another U1 snRNP component is affected. The only U1
snRNP component thus far shown to interact directly with yeast CBC is
Mud10p/Snu56p (Fortes et al. 1999
). This protein is
present in U1 snRNPs in luc7 mutant cells (Fig. 5D; data not
shown). The reduction in CBC interaction with U1 snRNP in these cells
may therefore either be due to the lack of an as yet uncharacterized
interaction with CBC, or to a change in U1 snRNP that prevents
CBC-Snu56p interaction. Note that although yCBC is not essential,
whereas Luc7p is, mediating interaction with CBC cannot be the sole
function of Luc7p.
The data, together with recent work on Nam8p (Puig et al. 1999
),
strongly suggest that not all 5' splice site-U1 snRNP interactions are identical, and that different U1 snRNP components will
differentially affect the splicing of different introns. This may
result from interaction between U1 snRNP components and other splicing
factors, like yCBC in the case of Luc7p, or with the pre-mRNA, in the
case of Nam8p and several other U1 snRNP proteins (Nakagawa and Ogawa 1997
; Puig et al. 1999
; Zhang and Rosbash 1999
). This suggestion of
substrate-specific functions for proteins that are generally considered
to belong to the basal splicing machinery is very analogous to the
recent observation that some components of basal RNA polymerase II
transcription complexes are only required for transcription from
certain specific promoters (Holstege et al. 1998
).
Yeast and vertebrate U1 snRNPs
Relatives of several of the yeast U1-specific proteins that have no
characterized vertebrate counterparts are present in the DNA
databases and are therefore probably present in vertebrate cells
(Gottschalk et al. 1998
; Puig et al. 1999
; this paper). Good examples
are the three human relatives of Luc7p described here. These proteins
contain not only the zinc finger region of Luc7p but also, unlike
Luc7p, carry multiple RS and RE repeats. These sequences are
characteristic of a large family of metazoan splicing factors
(Neugebauer et al. 1995
; Staknis and Reed 1995
), increasing the
likelihood that the vertebrate Luc7p relatives are involved in pre-mRNA
splicing. However, in contrast to the situation in yeast, these
proteins do not appear to be stable components of the U1 snRNP
(Lührmann et al. 1990
). This leads us to propose the following
possible rationale for the fact that yeast U1 snRNP contains many more
stable components than does vertebrate U1 snRNP.
Vertebrate splicing is subject to a much greater level of regulation
than yeast splicing (Black 1995
; Fu 1995
; Manley and Tacke 1996
). In
addition, even some nonregulated introns may require interaction with
exon-bound proteins, like the SR proteins, to be spliced efficiently
(Schaal and Maniatis 1999
). We therefore suggest that for splicing of
any specific vertebrate intron some, but probably not all, of the
homologs of the yeast-specific U1 snRNP proteins will have to be
assembled in situ with the core vertebrate U1 snRNP to form the
functional holo vertebrate U1 snRNP. This will involve binding of these
proteins to either the pre-mRNA directly in a sequence-dependent
manner, analogous to that of Nam8p (Puig et al. 1999
), or to other
proteins that bind to the pre-mRNA. The result would effectively
increase the available functional complexity of the U1 snRNP.
Examples of other proteins that could influence U1 snRNP composition
include mammalian CBC, which might recruit a mammalian Luc7p homolog to
the cap-proximal 5' splice site via direct or indirect
interactions. An alternative way to bring in human Luc7p, perhaps a
different homolog of Luc7p, to a 5' splice site might be through
proteins bound to an exon enhancer. The composition of U1 snRNP could
therefore be different on different 5' splice sites in a
context-dependent manner. In this way, many different combinations of
factors could potentially give rise to an active spliceosome,
increasing the potential for splicing regulation. This hypothesis could
also help to explain why vertebrate splicing is so dependent on the SR
protein family that helps assemble spliceosomes through networks of
weak protein-protein interactions, whereas yeast has either no or very
few SR proteins. Much further work will be required to test this
hypothesis, but there is preliminary evidence that even the much more
stable holo yeast U1 snRNP may not be of uniform composition. It was
reported that after deletion of the NAM8 gene another yeast U1
snRNP protein, Snu65p, replaced Nam8p and became a much more abundant
component of the yeast U1 snRNP population (Gottschalk et al. 1998
).
| |
Materials and methods |
|---|
|
|
|---|
Media, strains, and biological materials
Standard media and techniques were used for yeast (Sherman 1991
)
and E. coli manipulation (Sambrook et al. 1989
). Growth curves were assayed as described (Fortes et al. 1999
) and yeast was
transformed by the lithium acetate method (Ito et al. 1983
).
The wild-type strains used were the diploid BSY320
(MATa/MAT
; leu2-3, 112/leu2-3, 112;
arg4/arg4; ade2/ade2; trp1-289/trp1-289; ura3-52/ura3-52) and the haploid
MGD425-13D (Séraphin et al. 1988
). Mutant strains were PF433
(MATa; ade2; ade3; his3; leu2-3,112; trp1; ura3;
ycbp80/gcr3::TRP1; ycbp20/mud13::HIS3; [pHT8020; YCBP80/GCR3;
YCBP20/MUD13; URA3; ADE3]; luc7-2) isolated in a synthetic
lethal screen with yCBC (Fortes et al. 1999
) and WR244 (MATa,
ura3, leu2, can1; cyh2; luc7-1), a
temperature-sensitive strain that was selected as follows. Strain WR140
(MATa, cdc15-7, ura3, trp1, ade1, can1, cyh2) was mutagenized
with ethyl methane sulfonate to 40% viability at 23°C. Replica-plated
colonies were screened for loss of viability after a 3-hr incubation at
36°C, followed by downshifting to 23°C. Of 49,582 colonies screened, 49 candidates lost viability after incubation at 36°C. A subset of
these candidates were secondarily screened for those that accumulated as microcolonies of at least two to four cells following the shift to
36°C and that in unsonicated, fixed samples exhibited two
well-separated DAPI-staining bodies. By these secondary screens, 25 candidates were interpreted as being able to reach or pass late-nuclear
division. One of these candidates, strain 15A286, was shown through a
series of crosses and complementation experiments to contain a
temperature-sensitive allele of LUC7, luc7-1. Strain
WR244 was derived from 15A286 through standard crosses.
To tag Nam8p, Mud10p, and Luc7p, a URA3 marker fused to the
sequence coding for two IgG-binding domains of protein A (Puig et al.
1998
) was introduced in frame with the NAM8, MUD10,
and LUC7 coding regions. To obtain the NAM8-ProtA strain,
BSY593 was used (Gottschalk et al. 1998
), MUD10-ProtA (O. Puig,
unpubl.), and LUC7-ProtA strains were obtained from MGD425-13D and
luc7-1-ProtA was similarly constructed from WR244. Western blot
analysis and PCR were used to verify the structure of the tagged genes.
The same ProtA-URA3 construct was introduced in the genome of BSY320 to disrupt the LUC7 gene completely. For the diploid strain,
successful gene disruption was confirmed by PCR.
NAM8 was also fused to the TAP tag (Rigaut et al. 1999
). This
fragment was introduced in frame with the NAM8 gene into the genome of MGD425-13D strain to obtain the strain NAM8-TAP (O. Puig,
unpubl.) or into the genome of the WR244 strain. Western blot analysis
and PCR were used to verify the structure of the tagged genes.
DNA constructs
Oligonucleotides corresponding to position
400 and position
+205 relative to the LUC7 ORF were used to PCR amplify the
wild-type LUC7 gene, the luc7-1 temperature-sensitive
allele, and the luc7-2 synthetic lethal allele. These DNA
fragments were introduced into the BamHI site of pRS315
(pLEU), a single copy plasmid with a LEU2 marker (Sikorski and
Hieter 1989
) to generate pLEU-LUC7, pLEU-luc7-1, and pLEU-luc7-2, respectively.
pET-Luc7 contains LUC7 ligated between the NdeI and BamHI sites of pET21a. His-tagged Luc7p can be expressed from this plasmid in E. coli under the control of T7 promoter and purified with Ni-NTA column chromatography (Clontech).
Reporters used to analyze commitment complexes are transcribed from
pBS195, encoding wild-type RP51 sequences and pBS199, derived from a
pBS195 in which the UACUAAC branchpoint region has been deleted
(Séraphin and Rosbash 1989a
).
Reporters used to analyze in vivo splicing efficiency have been
described previously. All express RP51A pre-mRNA under the control of a
GAL inducible promoter; wild-type intron (pHZ18; Teem and Rosbash
1983
); 5' splice mutant GUAUaU (pHZ12; Jacquier et al. 1985
), and
branchpoint mutant UAuUAAC (pBS64; Pascolo and Séraphin 1997
).
The reporters with wild-type and mutant-duplicated 5' splice sites,
pBS450 (AG/AG), pBS452 (AG/UC), pBS456 (UC/AG), and pBS458 (UC/UC) have been
described (Séraphin and Kandels-Lewis 1993
).
Sequence analysis
Sequences were compiled and analyzed with computer software from
the Wisconsin Package version 9.1, Genetics Computer Group (GCG),
Madison, WI, BLAST (Altschul et al. 1997
), and Clustal_X (Thompson et
al. 1998
). ceLuc7A1 is predicted from C. elegans cosmid C50D2
(GenBank accession no. AF040642) and is similar to the predicted gene
product C50D2.8 (accession no. 2746789), except that the last two exons
are encoded by C50D2 120606-12659 and 12074-12247,
respectively. ceLuc7A2 is identical to the predicted C. elegans protein Y119D3_450.D. This sequence was produced by the
C. elegans Sequencing Group at the Sanger Centre and can be obtained from ftp://ftp.sanger.ac.uk/pub/databases/wormpep/excluded. ceLuc7B is identical to the C. elegans predicted gene product B0495.8 (accession no. Q09217). hLuc7A was derived by clustering of
human ESTs with accession numbers AA535263, AA311424, AA451779,
AA331496, AA332577, R94890, AA587998, N55709, AA493284, AA737596, and
AA628673. hLuc7B1 was derived by clustering of human ESTs with
accession numbers AA143197, AA352322, AA730774, N29757, AA143213, AA613804, C21369, T91335, AA317465, AA621718, H24668, W95695, and
human genomic sequences with accession numbers Z69706 (nucleotides
16971-17147) and Z69890 (nucleotides 849-992 and 2923-3033). hLuc7B2
was derived from human ESTs AA009903, N91986, Z44294, AA081610, H17407,
R73628, AA213413, AA496763, H17408, T62184, AA307963, N25025, and Z44289. Luc7 proteins are predicted in D. melanogaster from ESTs AA942407, AA439479, and AI107196 (dmLuc7A) and from ESTs AI258257,
AI292994, AA978748, AA951418, AA802732, AA390380, AA949554, and
AA201483 (dmLuc7B).
Protein and RNA analysis in vitro
Splicing mini-extracts (Séraphin and Rosbash 1989a
) of
control or protein A-tagged wild-type strains (NAM8-ProtA,
MUD10-ProtA, and LUC7-ProtA) were used to characterize binding
partners of Luc7p. Luc7-1p interactions were studied in WR244 and a
strain derived from WR244 carrying luc7-1p-ProtA and either
Nam8p-ProtA or Mud10p-ProtA. As a control, the same strains
transformed with the pLEU-LUC7 wild-type plasmid were used. Cells were
grown at 30°C to an optical density at 600 nm of 1 and shifted to
37°C for 2 or 5 hr. Total RNA (Pikielny and Rosbash 1985
) or
splicing mini-extracts (Séraphin and Rosbash 1989a
) were isolated
from these cells at permissive or restrictive temperatures. U1 and U2
snRNA levels were analyzed by primer extension as described below.
Splicing mini-extracts were incubated in IPP buffer (10 mM
Tris-HCl at pH 8.0, 150 mM NaCl, and 0.1% NP40) with rabbit
IgG-agarose (Sigma), or with protein A agarose linked to
anti-2,2,7-trimethylguanosine (Ab-1, Calbiochem), anti-Snu71p,
anti-Nam8p (Gottschalk et al. 1998
), or preimmune antibodies. The beads
were washed extensively with the same buffer and bound RNA or proteins
were analyzed. For RNA analysis, the input, flow-through, and bound
fractions were incubated with a proteinase K-SDS buffer (2 mg/ml proteinase K, 1 mg/ml tRNA, 0.6%
SDS, 25 mM EDTA, and 25 mM Tris-HCl at pH 8) for 20 min at 65°C. After phenol extraction and ethanol precipitation, RNAs
were analyzed by primer extension as described (Séraphin 1995
).
For protein analysis, proteins were eluted from the column either with
2 M NaCl containing IPP buffer or stepwise with the same
buffer containing 0.2, 0.5, and 2 M NaCl. After each elution, the column was washed extensively with the same buffer before the salt
concentration was changed. Proteins were analyzed by Western blotting
with anti-Snu71p, anti-Nam8p, anti-Npl3p, and anti-yCBP80 as described
(Görlich et al. 1996
; Gottschalk et al. 1998
). U1 snRNP
purification with the TAP (Tandem Affinity Purification) system was as
described (Rigaut et al. 1999
).
Splicing assays
For commitment complex assays, splicing mini-extracts were
incubated with CC1 or CC2 probes as described (Séraphin and
Rosbash 1989a
, 1991
). For supershift experiments, after commitment
complex formation extracts were incubated with buffer D or buffer D
containing 0.1 or 1 mg of rabbit IgG. When His-Luc7p was used,
extracts were mixed, before commitment complex formation, with buffer D
or 0.1, 0.2, or 0.5 mg of purified His-Luc7p in buffer D.
Splicing efficiency in vivo was assayed in either the WR244
(luc7-1) strain or WR244 transformed with a pLEU-LUC7
wild-type plasmid as a control. These strains were also transformed
with a collection of plasmids that express RP51A pre-mRNA under the control of a GAL-inducible promoter. Strains transformed with these
plasmids were grown at 30°C to an optical density at 600 nm of 0.8 in minimal medium containing 2% lactate-2% glycerol as carbon
sources. Cells were then maintained at 30°C or shifted to 37°C
for 20 min. 2% galactose was added to the cells to induce RP51A
pre-mRNA expression for 2 or 5 hr. Total RNA was isolated from the
cells (Pikielny and Rosbash 1985
) and RP51A RNAs were detected by
primer extension from the second exon with an oligonucleotide primer of
sequence CACGCTTGACGGTCTTGGT. The same protocol was used to analyze the
in vivo splicing efficiency in wild-type cells or cells genetically
depleted of CBC, Mud1p, Mud2p or Nam8p, but shift to 37°C was omitted.
| |
Acknowledgments |
|---|
We thank Oscar Puig for providing yeast strains, splicing reporter and other plasmid constructs, and stimulating discussions. We also acknowledge Alexander Gottschalk and Reinhard Lührmann for antibodies against Snu71p, Npl3p, and Nam8p, Dirk Görlich for antibody against yCBP80, Michael Rosbash and Nadja Abovich for mud1 and mud2 strains, and Angela Bachi and Matthias Wilm for mass spectrometric analysis of U1 snRNP fractions. Gert-Jan Arts, Scott Kuersten, Mutsuhito Ohno, Juan Valcárcel, Giulia Guarguaglini, Alexandra Segref, Martin Hetzer, Tobias Walther, Reinhard Lührmann, and David Tollervey provided valuable comments on the manuscript. P.F. was a recipient of fellowships from the Human Frontier Science Program Organization (HFSPO) and the European Union Training and Mobility Research (TMR) program.
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked `advertisement' in accordance with 18 USC section 1734 solely to indicate this fact.
| |
Footnotes |
|---|
Received March 30, 1999; revised version accepted July 23, 1999.
3 Corresponding author.
E-MAIL mattaj{at}embl-heidelberg.de; FAX +49 6221 387 518.
| |
References |
|---|
|
|
|---|